OTCMKTS:SBMFF Sino Biopharmaceutical (SBMFF) Stock Price, News & Analysis $0.70 0.00 (0.00%) As of 09/24/2026 Add Compare Share Share Stock Analysis Stock AnalysisChartNews and TrendsSEC FilingsShort Interest About Sino Biopharmaceutical Stock (OTCMKTS:SBMFF) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Sino Biopharmaceutical alerts:Sign Up Key Stats Today's Range$0.70▼$0.7050-Day Range$0.61▼$0.7552-Week Range$0.59▼$1.16VolumeN/AAverage Volume213 shsMarket Capitalization$13.04 billionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Sino Biopharmaceutical Limited is a China-based pharmaceutical company engaged in the research, development, manufacture and commercialization of medicines. The company offers prescription drugs and other pharmaceutical products across therapeutic areas that include oncology, respiratory diseases, hepatology, cardiovascular conditions, digestive disorders, infectious diseases and orthopedics. Its portfolio includes innovative medicines, specialty therapies and generic drugs. Among its better-known products are anlotinib hydrochloride, an oncology treatment marketed in China, and therapies used in areas such as hepatitis and respiratory disease. Sino Biopharmaceutical also maintains a pipeline of new drug candidates and participates in drug development through its research and development subsidiaries and partnerships. The company has historically operated primarily in mainland China, where its products are marketed through hospitals, pharmacies and other healthcare channels. It has also pursued international registrations, partnerships and market opportunities as part of its broader expansion strategy. Sino Biopharmaceutical is associated with major operating subsidiaries including Chia Tai Tianqing Pharmaceutical Group and Beijing Tide Pharmaceutical, which support its manufacturing, commercial and research activities.AI Generated. May Contain Errors. Read More Receive SBMFF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Sino Biopharmaceutical and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. SBMFF Stock News HeadlinesSino Biopharmaceutical’s HER2-Low Breast Cancer ADC Wins China NDA AcceptanceSeptember 15, 2026 | tipranks.comSino Biopharm Raises CT Tianqing Stake to 65% in RMB4.48 Billion DealSeptember 11, 2026 | tipranks.comALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings research points to the first half of 2026 as a particularly rough stretch for certain holdings. Some of America's most popular stocks could take serious damage as a radical market shift plays out. Analysts at Weiss Ratings have identified five names you may want to remove from your portfolio before this unfolds. If any of these are in your portfolio, now is the time to review your positions.September 25 at 1:00 AM | Weiss Ratings (Ad)Sino Biopharm’s Kylo-11 Shows Year-Long Lp(a) Cut in Phase I TrialAugust 30, 2026 | tipranks.comSino Biopharm Wins China, U.S. Green Lights for Next-Gen Nectin-4 ADC LM-364August 28, 2026 | tipranks.comSino Biopharmaceutical (SBMFF) Receives a Buy from CitiAugust 23, 2026 | theglobeandmail.comSino Biopharmaceutical Limited Unveils New Global Brand, SBP Group, to Accelerate International ExpansionAugust 19, 2026 | finance.yahoo.comSino Biopharmaceutical Declares 2026 Interim Dividend of HKD 0.07 Per ShareAugust 19, 2026 | tipranks.comSee More Headlines SBMFF Stock Analysis - Frequently Asked Questions How have SBMFF shares performed this year? Sino Biopharmaceutical's stock was trading at $0.8721 on January 1st, 2026. Since then, SBMFF shares have decreased by 20.3% and is now trading at $0.6952. How do I buy shares of Sino Biopharmaceutical? Shares of SBMFF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today9/25/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Biotechnology Sub-IndustryBiotechnology Current SymbolOTCMKTS:SBMFF Previous SymbolNASDAQ:SBMFF CIK1604982 Webwww.sinobiopharm.com Phone852-2802-9886Fax852-2880-0847Employees24,379Year Founded1997Profitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$4.02 billion Price / Sales3.25 Cash Flow$0.02 per share Price / Cash Flow29.75 Book Value$0.32 per share Price / Book2.17Miscellaneous Outstanding Shares18,760,720,000Free FloatN/AMarket Cap$13.04 billion OptionableNot Optionable Beta0.71 Social Links Options Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free Report This page (OTCMKTS:SBMFF) was last updated on 9/25/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredThe end may be near for these iconic stocksMarc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...Chaikin Analytics | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | SponsoredBank of America: 'Digital Dollar Inevitable'Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sino Biopharmaceutical Please log in to your account or sign up in order to add this asset to your watchlist. Share Sino Biopharmaceutical With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
